Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform

Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform

Introduction: Patients with advanced-stage non-small cell lung cancer (NSCLC) may benefit from a short time-to-treatment (TTT). Predictive biomarker testing is performed prior to treatment, as recommended by various international expert consensus bodies. Genetic testing is more time-intensive than i...

Full description

Bibliographic Details
Main Authors: Norbert Banyi, Deepu Alex, Curtis Hughesman, Kelly McNeil, Diana N. Ionescu, Carmen Ma, Stephen Yip, Barbara Melosky
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Oncology
Subjects:
EGFR testing
time-to-treatment
non-small cell lung cancer
genetic testing
lung molecular biomarkers
Online Access:https://www.mdpi.com/1718-7729/29/10/624

Similar Items

Similar Items